Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 4:10:903031.
doi: 10.3389/fcell.2022.903031. eCollection 2022.

Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders

Priyanka  1   2 , Pankaj Seth  1
Affiliations
Review

Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders

Priyanka et al. Front Cell Dev Biol. .

Abstract

Mortalin is a chaperone protein that regulates physiological functions of cells. Its multifactorial role allows cells to survive pathological conditions. Pharmacological, chemical, and siRNA-mediated downregulation of mortalin increases oxidative stress, mitochondrial dysfunction leading to unregulated inflammation. In addition to its well-characterized function in controlling oxidative stress, mitochondrial health, and maintaining physiological balance, recent evidence from human brain autopsies and cell culture-based studies suggests a critical role of mortalin in attenuating the damage seen in several neurodegenerative diseases. Overexpression of mortalin provides an important line of defense against accumulated proteins, inflammation, and neuronal loss, a key characteristic feature observed in neurodegeneration. Neurodegenerative diseases are a group of progressive disorders, sharing pathological features in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and HIV-associated neurocognitive disorder. Aggregation of insoluble amyloid beta-proteins and neurofibrillary tangles in Alzheimer's disease are among the leading cause of neuropathology in the brain. Parkinson's disease is characterized by the degeneration of dopamine neurons in substantia nigra pars compacta. A substantial synaptic loss leading to cognitive decline is the hallmark of HIV-associated neurocognitive disorder (HAND). Brain autopsies and cell culture studies showed reduced expression of mortalin in Alzheimer's, Parkinson's, and HAND cases and deciphered the important role of mortalin in brain cells. Here, we discuss mortalin and its regulation and describe how neurotoxic conditions alter the expression of mortalin and modulate its functions. In addition, we also review the neuroprotective role of mortalin under neuropathological conditions. This knowledge showcases the importance of mortalin in diverse brain functions and offers new opportunities for the development of therapeutic targets that can modulate the expression of mortalin using chemical compounds.

Keywords: Alzheimer’s disease; HIV-human immunodeficiency virus; Parkinson’s disease; mortalin; viral infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor RW declared a past co-authorship with the author PrS.

Figures

FIGURE 1
FIGURE 1
Tiff.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alzheimer's Disease (2022). 2022 Alzheimer's Disease Facts and Figures . Alzheimers Dement. 18(4), 700–789. 10.1002/alz.12638 PubMed Abstract | 10.1002/alz.12638 | Google Scholar - DOI - DOI - PubMed
    1. Abramov A. Y., Potapova E. V., Dremin V. V., Dunaev A. V. (2020). Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration. Life (Basel) 10 (7), 101. 10.3390/life10070101 PubMed Abstract | 10.3390/life10070101 | Google Scholar - DOI - DOI - PMC - PubMed
    1. Agrawal L., Louboutin J.-P., Reyes B. A. S., Van Bockstaele E. J., Strayer D. S. (2012). HIV-1 Tat Neurotoxicity: a Model of Acute and Chronic Exposure, and Neuroprotection by Gene Delivery of Antioxidant Enzymes. Neurobiol. Dis. 45 (2), 657–670. 10.1016/j.nbd.2011.10.005 PubMed Abstract | 10.1016/j.nbd.2011.10.005 | Google Scholar - DOI - DOI - PubMed
    1. Ali S. A., Huang M.-B., Campbell P. E., Roth W. W., Campbell T., Khan M., et al. (2010). Genetic Characterization of HIV Type 1 Nef-Induced Vesicle Secretion. AIDS Res. Hum. Retroviruses 26 (2), 173–192. 10.1089/aid.2009.0068 PubMed Abstract | 10.1089/aid.2009.0068 | Google Scholar - DOI - DOI - PMC - PubMed
    1. Anderson D. J., Politch J. A., Nadolski A. M., Blaskewicz C. D., Pudney J., Mayer K. H. (2010). Targeting Trojan Horse Leukocytes for HIV Prevention. AIDS 24 (2), 163–187. 10.1097/qad.0b013e32833424c8 PubMed Abstract | 10.1097/qad.0b013e32833424c8 | Google Scholar - DOI - DOI - PMC - PubMed